id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0152-0004,FDA,FDA-2011-E-0152,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2011-09-16T04:00:00Z,2011,9,2011-09-16T04:00:00Z,,2011-09-16T14:33:42Z,,0,0,0900006480f1f1b4
FDA-2011-E-0152-0003,FDA,FDA-2011-E-0152,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-04-26T04:00:00Z,2011,4,2011-04-26T04:00:00Z,,2011-04-26T19:10:44Z,,0,0,0900006480c39e20
FDA-2011-E-0152-0001,FDA,FDA-2011-E-0152,"Dainippono Sumitomo Pharma Co., Ltd. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP) Patent Extension Application",Other,APP-Application,2011-03-10T05:00:00Z,2011,3,2011-03-10T05:00:00Z,,2013-08-11T03:13:34Z,,0,0,0900006480c050b0
FDA-2011-E-0152-0002,FDA,FDA-2011-E-0152,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-03-10T05:00:00Z,2011,3,2011-03-10T05:00:00Z,,2013-07-27T23:47:03Z,,0,0,0900006480c04c39